Decline of Increased Risk Donor Offers on Waitlist Survival in Heart Transplantation

Michael S. Mulvihill, Morgan L. Cox, Muath Bishawi, Asishana A. Osho, Babatunde A. Yerokun, Cameron R. Wolfe, Adam D. DeVore, Chetan B. Patel, Matthew G. Hartwig, Carmelo A. Milano, Jacob N. Schroder

Research output: Contribution to journalLetterpeer-review

13 Scopus citations
Original languageEnglish (US)
Pages (from-to)2408-2409
Number of pages2
JournalJournal of the American College of Cardiology
Volume72
Issue number19
DOIs
StatePublished - Nov 6 2018
Externally publishedYes

Bibliographical note

Funding Information:
Please note: This work was supported by the National Institutes of Health–funded Cardiothoracic Surgery Trials Network 5U01HL088953-05 (to Dr. Cox) and the National Institutes of Health TL-1 clinical and translational science award 1UL1-TR001117-01 (National Center for Advancing Translational Sciences). Dr. Mulvihill is supported by the National Heart, Lung, and Blood Institute (F32HL132460-02). Dr. DeVore has received research funding from the American Heart Association, Amgen, National Heart, Lung, and Blood Institute, and Novartis; and has served as a consultant for Novartis. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Cite this